{"database": "lobbying", "table": "lobbying_activities", "rows": [[3483005, "447eeaee-1751-45cd-a8c4-c0b8d98d7f0b", "Q4", "VERTEX PHARMACEUTICALS INCORPORATED", 40027242, "VERTEX PHARMACEUTICALS INCORPORATED", 2025, "fourth_quarter", "VET", "Issues related to veteran's access to non-opioid alternatives and implementation of report language in the Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026 (PL 119-37).", "HOUSE OF REPRESENTATIVES,SENATE", null, 1110000, 0, 0, "2026-01-13T17:05:29-05:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["3483005"], "units": {}, "query_ms": 12.215188005939126, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}